Jung G, Brückner H
Hoppe Seylers Z Physiol Chem. 1981 Mar;362(3):291-304.
The N-terminal sequence 1-10 of interferon HuIFN-alpha(Ly) from human lymphoblasts Ser-Asp-Leu-Pro-Gln-Thr-His-Ser-Leu-Gly (LIF[1-10]) was synthesized by the Merrifield method. N-tert-Butyloxycarbonylglycin was esterified via its cesium salt with a chloro-methylated polystyrene-1% divinylbenzene support yielding a loading of 0.3 mmol/g. Double couplings, each with a five-fold excess of N-protected amino acid, were performed with N,N'-dicyclohexylcarbodiimide and 1-hydroxybenzotriazole, followed by an acetylation step. N-tert-Butyloxycarbonyl-L-amino acids with O-benzyl protection for serine, threonine, and Nim-2,4-dinitrophenyl protection for histidine, and N-fluorenylmethyloxycarbonylaspartic acid beta-tert-butyl ester were used. N-tert-Butyloxycarbonyl-glutamine was coupled as 4-nitrophenyl ester in the presence of 1-hydroxybenzotriazole. The butyloxycarbonyl groups of the residues 3 to 10 were removed with trifluoroacetic acid in dichloromethane; the 9-fluorenylmethyloxycarbonyl group was split off with diethylamine. After quantitative hydrazinolysis in dimethylformamide, chromatography on Sephadex LH-20 with methanol and reversed-phase chromatography on silica gel RP-8 with methanol/water 9:1, the decapeptide hydrazide Boc-Ser(Bzl)-Asp(But)-Leu-Pro-Gln-Thr(Bzl)-His-Ser(Bzl)-Leu-Gly-NH-HN2 was isolated in pure state. The partially protected decapeptide was characterized by 13C-NMR spectroscopy, analysed, and linked with poly(L-lysine) (molecular mass 37 300) via its azide and also using m-xylylene diisocyanate. After a deprotection step the polylysine-LIF[1-10] antigens were dialyzed and lyophilized. Furthermore the free decapeptide LIF[1-10] was split-off from the resin using HBr/CF3CO2H, followed by mercaptoethanol treatment. After purification on Sephadex G-15 with 0.1 M acetic acid and on the reversed-phase silicagel RP-8 with methanol/water 9:1 water soluble LIF-[1-10] was obtained in pure state as shown by thin-layer-chromatography, electrophoreses amino acid analysis and 13C-NMR spectroscopy.
采用Merrifield方法合成了来自人淋巴母细胞的干扰素HuIFN-α(Ly)的N端序列1-10,即Ser-Asp-Leu-Pro-Gln-Thr-His-Ser-Leu-Gly(LIF[1-10])。N-叔丁氧羰基甘氨酸通过其铯盐与氯甲基化聚苯乙烯-1%二乙烯基苯载体酯化,得到的负载量为0.3 mmol/g。使用N,N'-二环己基碳二亚胺和1-羟基苯并三唑进行双重偶联,每次偶联均使用五倍过量的N-保护氨基酸,随后进行乙酰化步骤。使用对丝氨酸、苏氨酸具有O-苄基保护、对组氨酸具有Nim-2,4-二硝基苯基保护的N-叔丁氧羰基-L-氨基酸,以及N-芴甲氧羰基天冬氨酸β-叔丁酯。N-叔丁氧羰基谷氨酰胺在1-羟基苯并三唑存在下以4-硝基苯酯形式偶联。用二氯甲烷中的三氟乙酸除去残基3至10的叔丁氧羰基;用二乙胺裂解9-芴甲氧羰基基团。在二甲基甲酰胺中进行定量肼解后,用甲醇在Sephadex LH-20上进行色谱分离,并用甲醇/水9:1在硅胶RP-8上进行反相色谱分离,得到纯态的十肽酰肼Boc-Ser(Bzl)-Asp(But)-Leu-Pro-Gln-Thr(Bzl)-His-Ser(Bzl)-Leu-Gly-NH-HN2。通过13C-NMR光谱对部分保护的十肽进行表征、分析,并通过其叠氮化物以及使用间苯二甲撑二异氰酸酯与聚(L-赖氨酸)(分子量37300)连接。经过脱保护步骤后,对聚赖氨酸-LIF[1-10]抗原进行透析和冻干。此外,使用HBr/CF3CO2H从树脂上裂解游离的十肽LIF[1-10],随后进行巯基乙醇处理。用0.1 M乙酸在Sephadex G-15上进行纯化,并用甲醇/水9:1在反相硅胶RP-8上进行纯化,通过薄层色谱、电泳、氨基酸分析和13C-NMR光谱显示,得到了纯态的水溶性LIF-[1-10]。